By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) - Caliper Life Sciences today reported preliminary fourth-quarter revenue of approximately $36 million and preliminary full-year revenue of $123.5 million.

The preliminary results reflect a 4 percent dip from $37.7 million in the fourth quarter of 2009 and a 5 percent decrease in annual revenues compared to 2009. The company said that organic revenues grew 10 percent year-over-year.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.